{
    "clinical_study": {
        "@rank": "50404", 
        "arm_group": [
            {
                "arm_group_label": "high VZV ELISPOT results", 
                "description": "high spot counts in ELISPOT"
            }, 
            {
                "arm_group_label": "low VZV ELISPOT results", 
                "description": "low spot counts in ELISPOT"
            }
        ], 
        "brief_summary": {
            "textblock": "VZV is one of the important opportunistic infection in transplant recipients.Until now,\n      there is no laboratory method to stratify the risk of VZV reactivation after solid organ\n      transplantation. Theoretically, VZV-specific cell-mediate immune response before solid organ\n      transplantation will further categorize the patients into high or low risk of VZV\n      development after solid organ transplantation. The investigators thus evaluate the\n      usefulness of VZV-specific ELISPOT assay in kidney transplant candidates to predict the\n      development of VZV infection after kidney transplantation."
        }, 
        "brief_title": "Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Kidney Transplantation", 
        "detailed_description": {
            "textblock": "We will develop VZV-specific ELISPOT assay, then perform this assay before transplantation.\n      We will evaluate whether this assay will predict zoster reactivation after transplantation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age 16 years or more\n\n          -  agree with written informed consent\n\n          -  WBC count 2000/uL or more\n\n        Exclusion Criteria:\n\n          -  no exclusion criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Kindeny transplant recipients"
            }
        }, 
        "enrollment": {
            "#text": "181", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02081729", 
            "org_study_id": "2014-0107"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 5, 2014", 
        "location": {
            "contact": {
                "email": "kimsunghanmd@hotmail.com", 
                "last_name": "Sung-Han Kim, MD", 
                "phone": "82-2-3010-3305"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "138-736"
                }, 
                "name": "Asan Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "2", 
        "official_title": "Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)", 
        "overall_contact": {
            "email": "kimsunghanmd@hotmail.com", 
            "last_name": "Sung-Han Kim, MD", 
            "phone": "82-2-3010-3305"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Sung-Han Kim, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "zoster development", 
            "safety_issue": "No", 
            "time_frame": "6 months after transplantation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02081729"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Sung-Han Kim", 
            "investigator_title": "Assocaite Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "mortality", 
            "safety_issue": "No", 
            "time_frame": "6 months after transplantation"
        }, 
        "source": "Asan Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "KAIST", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}